- FluroTech ( OTCPK:FLURF ) has entered into a share purchase agreement to sell all of the shares of FluroTest Diagnostic Systems, a wholly-owned subsidiary of the company, to an arm’s length individual.
- The purchaser has agreed to pay total cash consideration of $1.00 in lawful Canadian currency.
- The completion of the transaction is effective December 31, 2022.
- Additionally, the company announces the cancellation of an aggregate of 3.44M options to purchase shares previously granted under the company’s stock option plan to certain directors, officers and employees.
For further details see:
FluroTech to sell shares in FluroTest Diagnostic Systems